--- title: "LifeMD Pref Share LFMDP 8.875 Perp 10/15/22 | 10-Q: FY2026 Q1 Revenue: USD 50.16 M" type: "News" locale: "en" url: "https://longbridge.com/en/news/285444065.md" datetime: "2026-05-06T21:26:59.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/285444065.md) - [en](https://longbridge.com/en/news/285444065.md) - [zh-HK](https://longbridge.com/zh-HK/news/285444065.md) --- # LifeMD Pref Share LFMDP 8.875 Perp 10/15/22 | 10-Q: FY2026 Q1 Revenue: USD 50.16 M Revenue: As of FY2026 Q1, the actual value is USD 50.16 M. EPS: As of FY2026 Q1, the actual value is USD -0.2. EBIT: As of FY2026 Q1, the actual value is USD -8.929 M. LIFEMD, INC. manages its portfolio of brands within continuing operations as a single operating segment on a consolidated basis . #### Revenue For the three months ended March 31, 2026, total telehealth revenue, net, was $50,162,956, marking a decrease of approximately 1% compared to $50,887,899 for the same period in 2025 . Telehealth subscription revenue increased by approximately $280 thousand to $30,407,827 (61% of total revenue) in 2026, from $30,127,536 (59% of total revenue) in 2025, primarily due to an increase in online sales demand . Telehealth product revenue decreased by approximately $1.0 million to $19,755,129 (39% of total revenue) in 2026, from $20,760,363 (41% of total revenue) in 2025, mainly due to a decrease in online sales demand . #### Operational Metrics Cost of telehealth revenue decreased by approximately 27% to $5,925,499 (11.81% of revenue) in 2026, compared to $8,136,462 (15.99% of revenue) in 2025, driven by product mix, decreased telehealth product sales volume, and reduced shipping costs . Gross profit increased by 3% to $44,237,457 in 2026, from $42,751,437 in 2025 . Gross profit as a percentage of revenues rose to 88.19% in 2026 from 84.01% in 2025 . Total expenses increased by 21%, or approximately $9.2 million, to $53,166,529 in 2026, from $43,933,154 in 2025 . Selling and marketing expenses increased by approximately $7.6 million (34%) to $29,874,860 (59.56% of revenue) in 2026, from $22,272,924 (43.77% of revenue) in 2025, due to additional sales and marketing initiatives . General and administrative expenses increased by approximately $836 thousand to $15,176,355 (30.25% of revenue) in 2026, from $14,340,151 (28.18% of revenue) in 2025, mainly due to increased compensation costs ($1.1 million) and legal/professional fees ($200 thousand), partially offset by a decrease in stock-based compensation expense (- $1.1 million) . Other operating expenses increased by approximately $790 thousand (33%) to $3,179,946 (6.34% of revenue) in 2026, from $2,389,536 (4.70% of revenue) in 2025, primarily due to increased software subscriptions and depreciation expense . Customer service expenses increased by approximately $68 thousand (2%) to $3,139,305 (6.26% of revenue) in 2026, from $3,071,494 (6.04% of revenue) in 2025, mainly due to higher compensation costs . Development costs decreased by approximately $63 thousand (3%) to $1,796,063 (3.58% of revenue) in 2026, from $1,859,049 (3.65% of revenue) in 2025, due to lower third-party service provider costs .Operating loss from continuing operations was - $8,929,072 (-17.80% of revenue) in 2026, compared to - $1,181,717 (-2.32% of revenue) in 2025 . Net loss from continuing operations was - $8,872,596 in 2026, compared to - $1,645,355 in 2025 . Net (loss) income was - $8,872,596 in 2026, compared to $348,067 in 2025 . #### Cash Flow Net cash provided by operating activities was $444,624 for the three months ended March 31, 2026, a decrease from $3,068,387 in the same period of 2025 . Net cash used in investing activities was - $2,056,762 in 2026, compared to - $2,867,338 in 2025 . Net cash used in financing activities was - $696,043 in 2026, compared to - $812,563 in 2025 . #### Working Capital Working capital decreased by approximately $8.1 million, from $10,258,100 as of December 31, 2025, to $2,111,296 as of March 31, 2026 . This decrease was mainly attributed to a $2.3 million decrease in cash and an $8.0 million increase in current liabilities . #### Unique Metrics and Strategic Outlook As of March 31, 2026, LIFEMD, INC. served over 365,000 active patient subscribers . The Weight Management Program has grown to over 98,000 patient subscribers as of March 31, 2026, and the company expanded this program in September 2024 to include personalized non-GLP-1 treatment plans to grow its addressable market . The company has expanded insurance coverage for virtual primary care services to approximately 112 million lives as of March 31, 2026, with a goal to reach approximately 230 million lives (80% of commercially insured, 70% of Medicare Advantage, and Medicare Fee-for-Service beneficiaries) by June 1, 2026 . LIFEMD, INC. expects its existing cash of $34.5 million as of March 31, 2026, and net proceeds from its ATM Sales Agreement ($44.6 million available) to fund planned operating expenses and capital expenditures for at least the next 12 months . The company was out of compliance with its Consolidated Interest Coverage Ratio covenant as of March 31, 2026, due to increased selling and marketing costs, and is currently in discussions with Citizens Bank, N.A. for an amendment or waiver . ### Related Stocks - [LFMDP.US](https://longbridge.com/en/quote/LFMDP.US.md) ## Related News & Research - [Baxter Q2 2026 Earnings Preview](https://longbridge.com/en/news/294224876.md) - [What to Expect From Ulta Beauty’s Q2 2026 Earnings Report](https://longbridge.com/en/news/293941254.md) - [Equatorial Energia updates financial calendar for 2026 disclosures](https://longbridge.com/en/news/294368263.md) - [The Cooper Companies’ Q2 2026 Earnings: What to Expect](https://longbridge.com/en/news/293747625.md) - [International Paper Q2 2026 Earnings Preview](https://longbridge.com/en/news/294266740.md)